Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Regeneron Pharmaceuticals Inc (REGN)  
$1,024.09 20.57 (1.97%) as of 4:30 Wed 7/3


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 104,690,000
Market Cap: 107.21(B)
Last Volume: 378,341 Avg Vol: 759,306
52 Week Range: $692.45 - $1071.19
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
    S&P COMPOSITE 1500     NASDAQ BIOTECHNOLOGY
    NASDAQ COMPOSITE     S&P SMALLCAP 600
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  150
Guru Rank Value     : 6.9
Guru Occurances    : 2

 

            6 Months   1 Year   2 Year  
 
Company Profile   Regeneron Pharmaceuticals is a biotechnology company that discovers, invents, develops, manufactures, and commercializes medicines for serious diseases. Co.'s products include: EYLEA (aflibercept) Injection, which is used for the treatment of neovascular age-related macular degeneration, diabetic macular edema, macular edema following retinal vein occlusion, myopic choroidal neovascularization, diabetic retinopathy, and neovascular glaucoma; REGEN-COV, which is used for the treatment of COVID-19; and Kevzara (sarilumab) Solution for Subcutaneous Injection, which is used for the treatment of rheumatoid arthritis.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 191,758 236,826 311,409 468,643
Total Sell Value $188,359,854 $231,314,072 $294,701,490 $404,818,815
Total People Sold 7 13 16 18
Total Sell Transactions 16 39 65 127
End Date 2024-04-04 2024-01-02 2023-07-04 2022-07-04

   
Records found: 2433
  Page 64 of 98  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Vagelos P Roy Chairman of the Board   •       •      –    2013-05-06 4 S $263.15 $3,548,550 I/I (13,482) 114,018     -
   Shooter Eric M Director   –       •      –    2013-05-06 4 S $258.78 $2,619,648 I/I (10,000) 2,500     -
   Shooter Eric M Director   –       •      –    2013-05-06 4 A $0.00 $0 I/I 10,000 7,500     -
   Shooter Eric M Director   –       •      –    2013-05-06 4 S $256.49 $5,187,224 D/D (20,000) 0     -
   Shooter Eric M Director   –       •      –    2013-05-06 4 OE $24.41 $741,800 D/D 20,000 400     -
   Van Plew Daniel P SVP & General Mgr Industrial O   •       –      –    2013-05-06 4 D $260.44 $3,990,722 D/D (15,323) 24,461     -
   Van Plew Daniel P SVP & General Mgr Industrial O   •       –      –    2013-05-06 4 OE $16.80 $553,560 D/D 32,950 39,784     -
   Yancopoulos George President Regeneron Laboratori   •       •      –    2013-05-06 4 D $260.44 $26,888,607 D/D (103,243) 1,206,395     -
   Yancopoulos George President Regeneron Laboratori   •       •      –    2013-05-06 4 OE $13.00 $2,500,004 D/D 192,308 1,309,638     -
   Mccorkle Douglas S VP Controller & Asst Treasurer   •       –      –    2013-05-02 4 AS $241.45 $541,725 D/D (2,213) 4,000     -
   Schleifer Leonard S President & CEO   •       •      –    2013-05-01 4 AS $225.01 $23,765,289 D/D (100,000) 42,087     -
   Mccorkle Douglas S VP Controller & Asst Treasurer   •       –      –    2013-05-01 4 D $233.53 $855,187 D/D (3,662) 6,213     -
   Mccorkle Douglas S VP Controller & Asst Treasurer   •       –      –    2013-05-01 4 OE $52.03 $305,676 D/D 5,875 9,875     -
   Mccorkle Douglas S VP Controller and Asst Treasur   •       –      –    2013-04-12 4 AS $205.82 $660,235 D/D (3,129) 4,000     -
   Mccorkle Douglas S VP Controller and Asst Treasur   •       –      –    2013-04-11 4 D $204.57 $561,749 D/D (2,746) 7,129     -
   Mccorkle Douglas S VP Controller and Asst Treasur   •       –      –    2013-04-11 4 OE $30.63 $179,951 D/D 5,875 9,875     -
   Vagelos P Roy Chairman of the Board   •       •      –    2013-04-04 4 GD $0.00 $0 I/I 1,215 160,188     -
   Goldstein Joseph L Director   –       •      –    2013-04-01 4 AS $180.00 $900,000 D/D (5,000) 0     -
   Goldstein Joseph L Director   –       •      –    2013-04-01 4 OE $24.41 $122,050 D/D 5,000 5,000     -
   Brown Michael S Director   –       •      –    2013-03-21 4 AS $172.61 $2,599,022 D/D (15,000) 14,662     -
   Brown Michael S Director   –       •      –    2013-03-21 4 OE $18.61 $279,150 D/D 15,000 17,902     -
   Schleifer Leonard S President & CEO   •       •      –    2013-03-19 4 AS $175.02 $639,698 D/D (3,655) 142,087     -
   Schleifer Leonard S President & CEO   •       •      –    2013-03-13 4 AS $175.01 $815,897 D/D (4,662) 145,742     -
   Schleifer Leonard S President & CEO   •       •      –    2013-03-07 4 AS $175.13 $618,909 D/D (3,534) 150,404     -
   Schleifer Leonard S President & CEO   •       •      –    2013-03-06 4 AS $175.28 $12,101,570 D/D (69,003) 153,938     -
  2433 Records found
  Previous  60  61  62  63  64  65  66  67  68  69  Next   
  Page 64 of 98
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us